34
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Heart Muscle Antibodies in Myasthenia Gravis

, , &
Pages 263-267 | Received 18 Mar 1991, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Aliona Nacu, Jintana Bunpan Andersen, Vitalie Lisnic, Jone Furlund Owe & Nils Erik Gilhus. (2015) Complicating autoimmune diseases in myasthenia gravis: a review. Autoimmunity 48:6, pages 362-368.
Read now
Hakon Hofstad, Nils Erik Gilhus, Roald Matre & Johan A. Aarli. (1992) Non-Receptor Muscle Antibodies in Myasthenia Gravis are of Iggl and Igg4 Subclasses. Autoimmunity 12:4, pages 271-276.
Read now

Articles from other publishers (13)

H. Steven Block. 2021. Heart and Neurologic Disease. Heart and Neurologic Disease 111 123 .
J. B. Andersen, J. F. Owe, A. Engeland & N. E. Gilhus. (2014) Total drug treatment and comorbidity in myasthenia gravis: a population‐based cohort study. European Journal of Neurology 21:7, pages 948-955.
Crossref
Jared L. Antevil, Craig G. Carroll, Peter F. Roberts, Michael G. Johnston & Robert G. Strange. (2010) Myasthenia Gravis-An Unexpected Cause of Respiratory Failure and Reversible Left Ventricular Dysfunction after Cardiac Surgery. Journal of Cardiac Surgery 25:6, pages 662-664.
Crossref
Aiko Sakamoto, Miyuki Yamamoto, Masao Takahashi, Kohsuke Ajiki, Satoshi Ota, Akimichi Murakami, Makoto Mutou, Kamon Imai, Takahiro Maruta, Hiroaki Yoshikawa, Nobukazu Ishizaka, Hiroshi Yamashita, Yasunobu Hirata & Ryozo Nagai. (2010) A case of myasthenia gravis with cardiac fibrosis and easily provoked sustained ventricular tachycardia. Journal of Cardiology Cases 2:1, pages e41-e44.
Crossref
Jone Furlund Owe, Einar Skulstad Davidsen, Geir Egil Eide, Eva Gerdts & Nils Erik Gilhus. (2008) Left ventricular long-axis function in myasthenia gravis. Journal of Neurology 255:11, pages 1777-1784.
Crossref
Geir Helgeland, Steven P. Luckman, Fredrik R. Romi, Anne K. Jonassen & Nils Erik Gilhus. (2008) Myasthenia gravis sera have no effect on cardiomyocytes in vitro. Journal of Neuroimmunology 201-202, pages 74-79.
Crossref
Ansgar M. Brambrink & Jeffrey R. Kirsch. (2007) Perioperative Care of Patients with Neuromuscular Disease and Dysfunction. Anesthesiology Clinics 25:3, pages 483-509.
Crossref
Hemender S. Vats, Steven K. Richardson, Satyavardhan Pulukurthy & Brian Olshansky. (2004) Pericarditis in Myasthenia Gravis. Cardiology in Review 12:3, pages 134-137.
Crossref
William J. Groh. 2004. Cardiac Electrophysiology. Cardiac Electrophysiology 640 650 .
Maya Guglin, Joseph V. Campellone, Kathleen Heintz & Joseph E. Parrillo. (2003) Cardiac Disease in Myasthenia Gravis: A Literature Review. Journal of Clinical Neuromuscular Disease 4:4, pages 199-203.
Crossref
Manuel López-Cano, José María Ponseti Bosch, Eloi Espin Basany, José Luis Sánchez García & Manuel Armengol Carrasco. (2003) Factores predictivos de supervivencia en pacientes con miastenia grave y timoma. Medicina Clínica 120:11, pages 401-404.
Crossref
Elliot D. Rosenstein, Mark J. Zucker & Neil Kramer. (2000) Giant cell myocarditis: Most fatal of autoimmune diseases. Seminars in Arthritis and Rheumatism 30:1, pages 1-16.
Crossref
Stephen D. Cohle & J.T. Lie. (1996) Myasthenia gravis-associated systemic vasculitis and myocarditis with involvement of the cardiac conducting tissue. Cardiovascular Pathology 5:3, pages 159-162.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.